Patents Assigned to Longeveron LLC
  • Publication number: 20200129558
    Abstract: Compositions and methods for treating sexual dysfunction and enhancing sexual satisfaction using isolated populations of mesenchymal stem cells are disclosed.
    Type: Application
    Filed: June 15, 2018
    Publication date: April 30, 2020
    Applicant: LONGEVERON LLC
    Inventors: Joshua M. Hare, Darcy L. DiFede
  • Publication number: 20190290698
    Abstract: The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present invention also provides a method of treating subjects with symptoms of aging frailty by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells.
    Type: Application
    Filed: November 10, 2017
    Publication date: September 26, 2019
    Applicant: Longeveron LLC
    Inventors: Joshua M. Hare, Ana Marie Landin
  • Publication number: 20190038742
    Abstract: The present invention provides a method of enhancing an immune response to a vaccine by administering a vaccine and a population of isolated allogeneic human mesenchymal stem cells. The present invention also provides kits comprising a vaccine in a first container and a population of isolated allogeneic human mesenchymal stem cells in a second container.
    Type: Application
    Filed: February 2, 2017
    Publication date: February 7, 2019
    Applicant: Longeveron LLC
    Inventors: Joshua M. HARE, Ana Marie LANDIN